Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Herbst, Roy S, Prof, Baas, Paul, Prof, Kim, Dong-Wan, MD, Felip, Enriqueta, MD, Pérez-Gracia, José L, MD, Han, Ji-Youn, Prof, Molina, Julian, MD, Kim, Joo-Hang, Prof, Arvis, Catherine Dubos, MD, Ahn, Myung-Ju, Prof, Majem, Margarita, MD, Fidler, Mary J, MD, de Castro, Gilberto, MD, Garrido, Marcelo, MD, Lubiniecki, Gregory M, MD, Shentu, Yue, PhD, Im, Ellie, MD, Dolled-Filhart, Marisa, PhD, Garon, Edward B, MD
Published in The Lancet (British edition) (09.04.2016)
Published in The Lancet (British edition) (09.04.2016)
Get full text
Journal Article
Safety of combined PD‐1 pathway inhibition and radiation therapy for non‐small‐cell lung cancer: A multicentric retrospective study from the GFPC
Lesueur, Paul, Escande, Alexandre, Thariat, Juliette, Vauléon, Enora, Monnet, Isabelle, Cortot, Alexis, Lerouge, Delphine, Danhier, Serge, Dô, Pascal, Dubos‐Arvis, Catherine, Chouaïd, Christos, Gervais, Radj
Published in Cancer medicine (Malden, MA) (01.11.2018)
Published in Cancer medicine (Malden, MA) (01.11.2018)
Get full text
Journal Article
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
Park, Keunchil, Prof, Tan, Eng-Huat, MD, O'Byrne, Ken, Prof, Zhang, Li, Prof, Boyer, Michael, Prof, Mok, Tony, Prof, Hirsh, Vera, Prof, Yang, James Chih-Hsin, Prof, Lee, Ki Hyeong, MD, Lu, Shun, Prof, Shi, Yuankai, MD, Kim, Sang-We, MD, Laskin, Janessa, MD, Kim, Dong-Wan, Prof, Arvis, Catherine Dubos, MD, Kölbeck, Karl, MD, Laurie, Scott A, MD, Tsai, Chun-Ming, Prof, Shahidi, Mehdi, MD, Kim, Miyoung, MD, Massey, Dan, PhD, Zazulina, Victoria, MD, Paz-Ares, Luis, MD
Published in The lancet oncology (01.05.2016)
Published in The lancet oncology (01.05.2016)
Get full text
Journal Article
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)
Wislez, Marie, Mazieres, Julien, Lavole, Armelle, Zalcman, Gérard, Carre, Olivier, Egenod, Thomas, Caliandro, Raffaele, Dubos-Arvis, Catherine, Jeannin, Gaelle, Molinier, Olivier, Massiani, Marie-Ange, Langlais, Alexandra, Morin, Franck, Le Pimpec Barthes, Francoise, Brouchet, Laurent, Assouad, Jalal, Milleron, Bernard, Damotte, Diane, Antoine, Martine, Westeel, Virginie
Published in Journal for immunotherapy of cancer (01.10.2022)
Published in Journal for immunotherapy of cancer (01.10.2022)
Get full text
Journal Article
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression
Schuler, Martin, Tan, Eng-Huat, O’Byrne, Kenneth, Zhang, Li, Boyer, Michael, Mok, Tony, Hirsh, Vera, Yang, James Chih-Hsin, Lee, Ki Hyeong, Lu, Shun, Shi, Yuankai, Kim, Sang-We, Laskin, Janessa, Kim, Dong-Wan, Arvis, Catherine Dubos, Kölbeck, Karl, Massey, Dan, Märten, Angela, Paz-Ares, Luis, Park, Keunchil
Published in Journal of cancer research and clinical oncology (01.06.2019)
Published in Journal of cancer research and clinical oncology (01.06.2019)
Get full text
Journal Article
Assessment of multi-contaminant exposure in a cancer treatment center: a 2-year monitoring of molds, mycotoxins, endotoxins, and glucans in bioaerosols
Heutte, Natacha, André, Véronique, Dubos Arvis, Catherine, Bouchart, Valérie, Lemarié, Françoise, Legendre, Patrick, Votier, Edwige, Louis, Marie-Yolande, Madelaine, Stéphane, Séguin, Virginie, Gente, Stéphanie, Vérité, Philippe, Garon, David
Published in Environmental monitoring and assessment (2017)
Published in Environmental monitoring and assessment (2017)
Get full text
Journal Article
Relationship between level of PD-L1 expression and outcomes in the KEYNOTE-010 study of pembrolizumab vs docetaxel for previously treated, PD-L1–Positive NSCLC
Baas, Paul, Garon, Edward B., Herbst, Roy S., Felip, Enriqueta, Perez-Gracia, Jose Luis, Han, Ji-Youn, Molina, Julian R., Kim, Joo-Hang, Dubos Arvis, Catherine, Ahn, Myung-Ju, Majem, Margarita, Fidler, Mary J., Barlesi, Fabrice, Castro, Gilberto, Garrido, Marcelo, Shentu, Yue, Lubiniecki, Gregory M., Im, Ellie, Kim, Dong-Wan
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
P2.41 (also presented as PD1.06): Pembrolizumab vs Docetaxel for Previously Treated NSCLC (KEYNOTE-010): Archival vs New Tumor Samples for PD-L1 Assessment
Herbst, Roy S., Baas, Paul, Perez-Gracia, Jose L., Felip, Enriqueta, Kim, Dong-Wan, Han, Ji-Youn, Molina, Julian, Kim, Joo-Hang, Arvis, Catherine Dubos, Ahn, Myung-Ju, Majem, Margarita, Fidler, Mary Jo, Surmont, Veerle, De Castro, Gilberto, Garrido, Marcelo, Shentu, Yue, Dolled-Filhart, Marisa, Im, Ellie, Garon, Edward B.
Published in Journal of thoracic oncology (01.10.2016)
Published in Journal of thoracic oncology (01.10.2016)
Get full text
Journal Article
Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018
Guisier, Florian, Dubos-Arvis, Catherine, Viñas, Florent, Doubre, Helene, Ricordel, Charles, Ropert, Stanislas, Janicot, Henri, Bernardi, Marie, Fournel, Pierre, Lamy, Régine, Pérol, Maurice, Dauba, Jerome, Gonzales, Gilles, Falchero, Lionel, Decroisette, Chantal, Assouline, Pascal, Chouaid, Christos, Bylicki, Olivier
Published in Journal of thoracic oncology (01.04.2020)
Published in Journal of thoracic oncology (01.04.2020)
Get full text
Journal Article
Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1‒Positive, Advanced Non‒Small-Cell Lung Cancer in the KEYNOTE-010 Study
Herbst, Roy S, Garon, Edward B, Kim, Dong-Wan, Cho, Byoung Chul, Perez-Gracia, Jose L, Han, Ji-Youn, Arvis, Catherine Dubos, Majem, Margarita, Forster, Martin D, Monnet, Isabelle, Novello, Silvia, Szalai, Zsuzsanna, Gubens, Matthew A, Su, Wu-Chou, Ceresoli, Giovanni Luca, Samkari, Ayman, Jensen, Erin H, Lubiniecki, Gregory M, Baas, Paul
Published in Journal of clinical oncology (10.05.2020)
Published in Journal of clinical oncology (10.05.2020)
Get full text
Journal Article
Harmonizing SUVs in multicentre trials when using different generation PET systems: prospective validation in non-small cell lung cancer patients
Lasnon, Charline, Desmonts, Cédric, Quak, Elske, Gervais, Radj, Do, Pascal, Dubos-Arvis, Catherine, Aide, Nicolas
Published in European journal of nuclear medicine and molecular imaging (01.07.2013)
Published in European journal of nuclear medicine and molecular imaging (01.07.2013)
Get full text
Journal Article
TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)
Guigay, Joel, Fayette, Jerome, Mesia, Ricard, Lafond, Cedrik, Saada-Bouzid, Esma, Geoffrois, Lionnel, Martin, Laurent, Cupissol, Didier, Capitain, Olivier, Castanie, Helene, Vansteene, Damien, Schafhausen, Philippe, Dubos Arvis, Catherine, Even, Caroline, Sire, Christian, Delhommeau, Melissa, Michel, Cecile, Bourhis, Jean, Keilholz, Ulrich, Auperin, Anne
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Factors associated with better overall survival (OS) in patients with previously treated, PD-L1–expressing, advanced NSCLC: Multivariate analysis of KEYNOTE-010
Herbst, Roy S., Baas, Paul, Kim, Dong-Wan, Felip, Enriqueta, Perez-Gracia, Jose Luis, Han, Ji-Youn, Molina, Julian R., Kim, Joo-Hang, Dubos Arvis, Catherine, Ahn, Myung-Ju, Majem, Margarita, Fidler, Mary J., Castro, Gilberto, Garrido, Marcelo, Ellison, Misoo C., Samkari, Ayman, Lubiniecki, Gregory M., Garon, Edward B.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Off-Label Use of Crizotinib as a Neoadjuvant Treatment for a Young Patient When Conventional Chemotherapy Gave No Benefits in Stage IIIA Non-Small Cell Lung Cancer
Dumont, Delphine, Dô, Pascal, Lerouge, Delphine, Planchard, Gaëtane, Riffet, Marc, Dubos-Arvis, Catherine, Danhier, Serge, Gervais, Radj
Published in The American journal of case reports (15.08.2017)
Published in The American journal of case reports (15.08.2017)
Get full text
Journal Article
Pembrolizumab vs docetaxel for previously treated advanced NSCLC with a PD-L1 tumor proportion score (TPS) 1%-49%: Results from KEYNOTE-010
Garon, Edward B., Herbst, Roy S., Kim, Dong-Wan, Felip, Enriqueta, Perez-Gracia, Jose Luis, Han, Ji-Youn, Molina, Julian R., Kim, Joo-Hang, Dubos Arvis, Catherine, Ahn, Myung-Ju, Majem, Margarita, Fidler, Mary J., Gubens, Matthew A., Castro, Gilberto, Garrido, Marcelo, Shentu, Yue, Im, Ellie, Lubiniecki, Gregory M., Baas, Paul
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
First-line afatinib (A) vs gefitinib (G) for patients (pts) with EGFR mutation positive (EGFRm+) NSCLC (LUX-Lung 7): Patient-reported outcomes (PROs) and impact of dose modifications on efficacy and adverse events (AEs)
Hirsh, Vera, Yang, James Chih-Hsin, Tan, Eng-Huat, O'Byrne, Ken, Zhang, Li, Boyer, Michael J., Mok, Tony, Lee, Ki Hyeong, Lu, Shun, Shi, Yuankai, Kim, Sang-We, Laskin, Janessa J., Kim, Dong-Wan, Dubos Arvis, Catherine, Kölbeck, Karl, Schuler, Martin H., Massey, Dan, Maerten, Angela, Paz-Ares, Luis, Park, Keunchil
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Archival vs new tumor samples for assessing PD-L1 expression in the KEYNOTE-010 study of pembrolizumab (pembro) vs docetaxel (doce) for previously treated advanced NSCLC
Herbst, Roy S., Baas, Paul, Perez-Gracia, Jose Luis, Felip, Enriqueta, Kim, Dong-Wan, Han, Ji-Youn, Molina, Julian R., Kim, Joo-Hang, Dubos Arvis, Catherine, Ahn, Myung-Ju, Majem, Margarita, Fidler, Mary J., Surmont, Veerle, Castro, Gilberto, Garrido, Marcelo, Shentu, Yue, Dolled-Filhart, Marisa, Im, Ellie, Garon, Edward B.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocations: Clinical Characteristics and Management in a Real-Life Setting: a French Retrospective Analysis (GFPC 02–14 Study)
Auliac, Jean-Bernard, Monnet, Isabelle, Dubos-Arvis, Catherine, Chiappa, Anne Marie, Baize, Nathalie, Bota, Suzana, Vergnenegre, Alain, Doubre, Helene, Locher, Chrystele, Bizieux, Acya, Robinet, Gilles, Chouaid, Christos
Published in Targeted oncology (01.12.2017)
Published in Targeted oncology (01.12.2017)
Get full text
Journal Article
Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial
de Marinis, Filippo, Vergnenegre, Alain, Passaro, Antonio, Dubos-Arvis, Catherine, Carcereny, Enric, Drozdowskyj, Ana, Zeaiter, Ali, Perez-Moreno, Pablo, Rosell, Rafael
Published in Future oncology (London, England) (01.02.2015)
Published in Future oncology (London, England) (01.02.2015)
Get full text
Journal Article
OA03.07 KEYNOTE-010: Durable Clinical Benefit in Patients with Previously Treated, PD-L1-Expressing NSCLC Who Completed Pembrolizumab
Herbst, Roy, Garon, Edward, Kim, Dong-Wan, Cho, Byoung Chul, Gadgeel, Shirish, Léna, Hervé, Gúrpide, Alfonso, Han, Ji-Youn, Arvis, Catherine Dubos, Majem, Margarita, Forster, Martin, Monnet, Isabelle, Novello, Silvia, Saka, Hideo, Szalai, Zsuzsanna, Gubens, Matthew, Su, Wu-Chou, Lubiniecki, Gregory, Shentu, Yue, Ferraro, Geri, Baas, Paul
Published in Journal of thoracic oncology (01.01.2017)
Published in Journal of thoracic oncology (01.01.2017)
Get full text
Journal Article